Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guillaume Bonnefois"'
Autor:
Nassim Djebli, Pierre-Olivier Tremblay, Vincent Buchheit, Mario González-Sales, Guillaume Bonnefois, Georgina Meneses-Lorente, Francois Mercier, Nicolas Frey
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:997-1007
Entrectinib (ROZLYTREK®) is a CNS-active, potent, and selective inhibitor of ROS1, TRK A/B/C, and ALK kinase activity. It was recently approved for the treatment of ROS1-positive non-small cell lung cancer and NTRK gene fusion-positive solid tumors.
Autor:
Marie-Pierre Dubé, Jean-Claude Tardif, Jun Li, Jean-Lucien Rouleau, Fahima Nekka, Steven Sanche, Guillaume Bonnefois, Michel White, Imad Kassem, Simon de Denus, Jacques Turgeon
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 1, Pp 194-203 (2021)
Clinical and Translational Science, Vol 14, Iss 1, Pp 194-203 (2021)
Heart failure (HF) causes pathological changes in multiple organs, thus affecting the pharmacokinetics (PK) of drugs. The aim of this study was to investigate the PK of candesartan in patients with HF while examining significant covariates and their
Publikováno v:
Clinical and translational science. 15(4)
The recently released revised vancomycin consensus guideline endorsed area under the concentration-time curve (AUC) guided monitoring. Means to AUC-guided monitoring include pharmacokinetic (PK) equations and Bayesian software programs, with the latt
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 49(2)
To evaluate study designs and the influence of dispersion of body size, body composition and maturation of clearance or reliable estimation of allometric exponents. Non-linear mixed effects modeling and parametric bootstrap were employed to assess ho
Autor:
Nathalie H. Gosselin, Ulf Landmesser, Guillaume Bonnefois, Patrick F. Smith, Gregory S. Schwartz, Frederick J. Raal, Lorena Garcia Conde, Kausik K. Ray, Lawrence A. Leiter, R. Scott Wright, Wolfgang Koenig, David Kallend, Laura H Gunn
Publikováno v:
Journal of the American College of Cardiology. 77:1462
Autor:
Mario González-Sales, Pierre Olivier Tremblay, Guillaume Bonnefois, Fahima Nekka, Olivier Barrière, Julie Desrochers
Publikováno v:
The R Journal. 12:107
Publikováno v:
Mathematics in Industry ISBN: 9783319234120
Individualized dose adaptation usually requires Therapeutic Drug Monitoring (TDM) based on patient blood samplings. However this invasive approach, generally accompanied with discomfort and cost, is not always justified since it may occur that the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::703ab41dd139284680f9567c671acbc1
https://doi.org/10.1007/978-3-319-23413-7_141
https://doi.org/10.1007/978-3-319-23413-7_141